Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
DMPI > SEC Filings for DMPI > Form 8-K on 29-Oct-2013All Recent SEC Filings




Other Events

Item 8.01 Other Events.

As of October 29, 2013, the Board of Directors of DelMar Pharmaceuticals, Inc. (the "Company") has authorized its directors and officers to purchase the Company's common stock in the open market for their own personal accounts in accordance with SEC Rule 10b-18.

Individuals specified in the authorization include:

Mr. Jeffrey A. Bacha - Chairman & Chief Executive Officer and Director

Mr. Scott Praill - Chief Financial Officer

Dr. Dennis Brown - Chief Scientific Officer and Director

Dr. William J. Garner - Director

Mr. John K. Bell - Director

Mr. Robert J. Toth, Jr. - Director

Share purchases, if any, will be made by these individuals independently for their own accounts with personal funds. Each individual will be acting separately and not as part of an aggregate purchasing group. Company funds will not be used for share purchases. The share purchase authorization does not obligate any of the individuals named herein to purchase any specific number of shares and may be suspended or terminated at any time without prior notice.

Share purchases, if any, may be made in the open market or in private transactions. Any share purchases will be made in compliance with SEC Rule 10b-18. In accordance with Rule 10b-18, the timing and actual number of shares that may be purchased will depend on a variety of factors including price, market conditions and applicable legal requirements. Any transactions will be disclosed publicly through Form 4 filings with the Securities and Exchange Commission.

  Add DMPI to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for DMPI - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.